{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "1f61a6c4",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pylab as plt\n",
    "import seaborn as sns\n",
    "\n",
    "plt.style.use('ggplot')\n",
    "pd.set_option('display.max_columns', 200)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "3584331b",
   "metadata": {},
   "outputs": [],
   "source": [
    "dfel=pd.read_csv(\"eligibilty_test.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "e2e27062",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['id', 'nct_id', 'sampling_method', 'gender', 'minimum_age',\n",
       "       'maximum_age', 'healthy_volunteers', 'population', 'criteria',\n",
       "       'gender_description', 'gender_based', 'adult', 'child', 'older_adult'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dfel.columns\n",
    "# df.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "904b9b36",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "id                     int64\n",
       "nct_id                object\n",
       "sampling_method       object\n",
       "gender                object\n",
       "minimum_age           object\n",
       "maximum_age           object\n",
       "healthy_volunteers    object\n",
       "population            object\n",
       "criteria              object\n",
       "gender_description    object\n",
       "gender_based          object\n",
       "adult                 object\n",
       "child                 object\n",
       "older_adult           object\n",
       "dtype: object"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dfel.dtypes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "c4b63a36",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>5.000000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mean</th>\n",
       "      <td>6.195466e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>std</th>\n",
       "      <td>7.444846e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>min</th>\n",
       "      <td>5.955908e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25%</th>\n",
       "      <td>6.159126e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50%</th>\n",
       "      <td>6.159250e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75%</th>\n",
       "      <td>6.260155e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>max</th>\n",
       "      <td>6.361043e+06</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                 id\n",
       "count  5.000000e+02\n",
       "mean   6.195466e+06\n",
       "std    7.444846e+04\n",
       "min    5.955908e+06\n",
       "25%    6.159126e+06\n",
       "50%    6.159250e+06\n",
       "75%    6.260155e+06\n",
       "max    6.361043e+06"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dfel.describe()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "f0581168",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "id                      0\n",
       "nct_id                  0\n",
       "sampling_method       394\n",
       "gender                  0\n",
       "minimum_age            33\n",
       "maximum_age           222\n",
       "healthy_volunteers     11\n",
       "population            394\n",
       "criteria                0\n",
       "gender_description    489\n",
       "gender_based          475\n",
       "adult                   0\n",
       "child                   0\n",
       "older_adult             0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dfel.isna().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "e183545e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>nct_id</th>\n",
       "      <th>sampling_method</th>\n",
       "      <th>gender</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>population</th>\n",
       "      <th>criteria</th>\n",
       "      <th>gender_description</th>\n",
       "      <th>gender_based</th>\n",
       "      <th>adult</th>\n",
       "      <th>child</th>\n",
       "      <th>older_adult</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>6260055</td>\n",
       "      <td>NCT05050916</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>19 Years</td>\n",
       "      <td>40 Years</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>* INCLUSION CRITERIA:~In order to be eligible ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>f</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>6260056</td>\n",
       "      <td>NCT01092156</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Pregnant women who inten...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>6260057</td>\n",
       "      <td>NCT01218256</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>30 Years</td>\n",
       "      <td>80 Years</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* type 2 diabetes mellitus...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6260058</td>\n",
       "      <td>NCT03240432</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>60 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~To be eligible for the stu...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>6260059</td>\n",
       "      <td>NCT04348578</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>65 Years</td>\n",
       "      <td>t</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* necrotic, single root te...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        id       nct_id sampling_method  gender minimum_age maximum_age  \\\n",
       "0  6260055  NCT05050916             NaN  FEMALE    19 Years    40 Years   \n",
       "1  6260056  NCT01092156             NaN  FEMALE    18 Years         NaN   \n",
       "2  6260057  NCT01218256             NaN     ALL    30 Years    80 Years   \n",
       "3  6260058  NCT03240432             NaN     ALL    60 Years         NaN   \n",
       "4  6260059  NCT04348578             NaN     ALL    18 Years    65 Years   \n",
       "\n",
       "  healthy_volunteers population  \\\n",
       "0                  f        NaN   \n",
       "1                  t        NaN   \n",
       "2                  f        NaN   \n",
       "3                  t        NaN   \n",
       "4                  t        NaN   \n",
       "\n",
       "                                            criteria gender_description  \\\n",
       "0  * INCLUSION CRITERIA:~In order to be eligible ...                NaN   \n",
       "1  Inclusion Criteria:~* Pregnant women who inten...                NaN   \n",
       "2  Inclusion Criteria:~* type 2 diabetes mellitus...                NaN   \n",
       "3  Inclusion Criteria:~To be eligible for the stu...                NaN   \n",
       "4  Inclusion Criteria:~* necrotic, single root te...                NaN   \n",
       "\n",
       "  gender_based adult child older_adult  \n",
       "0          NaN     t     f           f  \n",
       "1          NaN     t     f           t  \n",
       "2          NaN     t     f           t  \n",
       "3          NaN     t     f           t  \n",
       "4          NaN     t     f           t  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dfel.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "d9c6b518",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>nct_id</th>\n",
       "      <th>sampling_method</th>\n",
       "      <th>gender</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>population</th>\n",
       "      <th>criteria</th>\n",
       "      <th>gender_description</th>\n",
       "      <th>gender_based</th>\n",
       "      <th>adult</th>\n",
       "      <th>child</th>\n",
       "      <th>older_adult</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Empty DataFrame\n",
       "Columns: [id, nct_id, sampling_method, gender, minimum_age, maximum_age, healthy_volunteers, population, criteria, gender_description, gender_based, adult, child, older_adult]\n",
       "Index: []"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dfel.loc[df.duplicated()]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9622d1f9",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7427320a",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d937f7f7",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "40cae4a3",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "03bd0fa4",
   "metadata": {},
   "outputs": [],
   "source": [
    "df=pd.read_csv(\"usecase1_test.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "fbffce5e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['NCT Number', 'Study Title', 'Study URL', 'Acronym', 'Study Status',\n",
       "       'Brief Summary', 'Study Results', 'Conditions', 'Interventions',\n",
       "       'Primary Outcome Measures', 'Secondary Outcome Measures',\n",
       "       'Other Outcome Measures', 'Sponsor', 'Collaborators', 'Sex', 'Age',\n",
       "       'Phases', 'Enrollment', 'Funder Type', 'Study Type', 'Study Design',\n",
       "       'Other IDs', 'Start Date', 'Primary Completion Date', 'Completion Date',\n",
       "       'First Posted', 'Results First Posted', 'Last Update Posted',\n",
       "       'Locations', 'Study Documents'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "d49b475c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 500 entries, 0 to 499\n",
      "Data columns (total 30 columns):\n",
      " #   Column                      Non-Null Count  Dtype  \n",
      "---  ------                      --------------  -----  \n",
      " 0   NCT Number                  500 non-null    object \n",
      " 1   Study Title                 500 non-null    object \n",
      " 2   Study URL                   500 non-null    object \n",
      " 3   Acronym                     113 non-null    object \n",
      " 4   Study Status                500 non-null    object \n",
      " 5   Brief Summary               500 non-null    object \n",
      " 6   Study Results               500 non-null    object \n",
      " 7   Conditions                  500 non-null    object \n",
      " 8   Interventions               471 non-null    object \n",
      " 9   Primary Outcome Measures    490 non-null    object \n",
      " 10  Secondary Outcome Measures  403 non-null    object \n",
      " 11  Other Outcome Measures      38 non-null     object \n",
      " 12  Sponsor                     500 non-null    object \n",
      " 13  Collaborators               90 non-null     object \n",
      " 14  Sex                         499 non-null    object \n",
      " 15  Age                         500 non-null    object \n",
      " 16  Phases                      342 non-null    object \n",
      " 17  Enrollment                  493 non-null    float64\n",
      " 18  Funder Type                 500 non-null    object \n",
      " 19  Study Type                  500 non-null    object \n",
      " 20  Study Design                497 non-null    object \n",
      " 21  Other IDs                   500 non-null    object \n",
      " 22  Start Date                  494 non-null    object \n",
      " 23  Primary Completion Date     477 non-null    object \n",
      " 24  Completion Date             476 non-null    object \n",
      " 25  First Posted                500 non-null    object \n",
      " 26  Results First Posted        151 non-null    object \n",
      " 27  Last Update Posted          500 non-null    object \n",
      " 28  Locations                   431 non-null    object \n",
      " 29  Study Documents             52 non-null     object \n",
      "dtypes: float64(1), object(29)\n",
      "memory usage: 117.3+ KB\n",
      "None\n",
      "    NCT Number                                        Study Title  \\\n",
      "0  NCT03302091  A Study in People With Normal Kidney Function ...   \n",
      "1  NCT01948791  16w Interventional Study on Titration and Dose...   \n",
      "2  NCT04621591           Case Series With Saneso 360° Gastroscope   \n",
      "3  NCT03130491  European Study Evaluating the EMBLOK Embolic P...   \n",
      "4  NCT01580891  Evaluate the Clinical Equivalence of Two Nafti...   \n",
      "\n",
      "                                      Study URL   Acronym Study Status  \\\n",
      "0  https://clinicaltrials.gov/study/NCT03302091       NaN    COMPLETED   \n",
      "1  https://clinicaltrials.gov/study/NCT01948791  INSTINCT    COMPLETED   \n",
      "2  https://clinicaltrials.gov/study/NCT04621591       NaN    COMPLETED   \n",
      "3  https://clinicaltrials.gov/study/NCT03130491       NaN    COMPLETED   \n",
      "4  https://clinicaltrials.gov/study/NCT01580891       NaN    COMPLETED   \n",
      "\n",
      "                                       Brief Summary Study Results  \\\n",
      "0  The primary objective of the current study is ...           YES   \n",
      "1  To investigate the efficacy of Exelon capsule ...           YES   \n",
      "2  To confirm the procedural performance of the S...            NO   \n",
      "3  The primary objective is to evaluate the perfo...            NO   \n",
      "4  The objective of this study is to evaluate the...            NO   \n",
      "\n",
      "                    Conditions  \\\n",
      "0  Renal Insufficiency|Healthy   \n",
      "1          Alzheimer's Disease   \n",
      "2                EGD Procedure   \n",
      "3         Aortic Valve Disease   \n",
      "4                  Tinea Pedis   \n",
      "\n",
      "                                       Interventions  \\\n",
      "0                                   DRUG: BI 1467335   \n",
      "1                                       DRUG: ENA713   \n",
      "2                    DEVICE: Saneso 360° gastroscope   \n",
      "3  PROCEDURE: Transcatheter Aortic Valve Replacem...   \n",
      "4  DRUG: Naftifine HCl Cream 1%|DRUG: Naftin® (Na...   \n",
      "\n",
      "                            Primary Outcome Measures  \\\n",
      "0  Area Under the Concentration-time Curve of BI ...   \n",
      "1  Mean Change From Baseline in the Alzheimer's D...   \n",
      "2  Successful EGD, Procedure success is assessed ...   \n",
      "3  Performance Endpoint, successful insertion, pl...   \n",
      "4  Therapeutic Cure, Patients with both mycologic...   \n",
      "\n",
      "                          Secondary Outcome Measures  \\\n",
      "0  Area Under the Concentration-time Curve of BI ...   \n",
      "1  Change From Baseline in the Alzheimer's Diseas...   \n",
      "2  Endoscopist qualitative rating of the Saneso 3...   \n",
      "3  Safety Endpoint (Rate of MACCE), Rate of MACCE...   \n",
      "4                                                NaN   \n",
      "\n",
      "                              Other Outcome Measures  \\\n",
      "0                                                NaN   \n",
      "1                                                NaN   \n",
      "2                                                NaN   \n",
      "3  Efficacy Endpoint, Reduction in embolic burden...   \n",
      "4                                                NaN   \n",
      "\n",
      "                               Sponsor             Collaborators  Sex  \\\n",
      "0                 Boehringer Ingelheim                       NaN  ALL   \n",
      "1             Novartis Pharmaceuticals                       NaN  ALL   \n",
      "2                          Saneso Inc.  West Virginia University  ALL   \n",
      "3  Innovative Cardiovascular Solutions     Meditrial Europe Ltd.  ALL   \n",
      "4             Taro Pharmaceuticals USA                       NaN  ALL   \n",
      "\n",
      "                  Age  Phases  Enrollment Funder Type      Study Type  \\\n",
      "0  ADULT, OLDER_ADULT  PHASE1        20.0    INDUSTRY  INTERVENTIONAL   \n",
      "1  ADULT, OLDER_ADULT  PHASE4       222.0    INDUSTRY  INTERVENTIONAL   \n",
      "2  ADULT, OLDER_ADULT     NaN        22.0    INDUSTRY  INTERVENTIONAL   \n",
      "3  ADULT, OLDER_ADULT     NaN        28.0    INDUSTRY  INTERVENTIONAL   \n",
      "4  ADULT, OLDER_ADULT  PHASE1      1053.0    INDUSTRY  INTERVENTIONAL   \n",
      "\n",
      "                                        Study Design  \\\n",
      "0  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
      "1  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
      "2  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
      "3  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
      "4  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
      "\n",
      "                  Other IDs  Start Date Primary Completion Date  \\\n",
      "0  1386-0002|2017-002180-18  2017-10-17              2018-08-16   \n",
      "1              CENA713BCN05     2014-08                 2015-09   \n",
      "2               SAN360UGICL  2020-08-01              2020-08-30   \n",
      "3               CLP002-2016  2017-03-08              2021-11-01   \n",
      "4               NTFC 1105.0     2012-05                 2013-03   \n",
      "\n",
      "  Completion Date First Posted Results First Posted Last Update Posted  \\\n",
      "0      2018-08-16   2017-10-04           2021-06-04         2021-06-04   \n",
      "1         2015-09   2013-09-24           2017-02-13         2017-02-13   \n",
      "2      2020-09-09   2020-11-09                  NaN         2020-11-10   \n",
      "3      2022-01-28   2017-04-26                  NaN         2024-03-05   \n",
      "4         2013-07   2012-04-19                  NaN         2014-05-06   \n",
      "\n",
      "                                           Locations  \\\n",
      "0  CRS Clinical Research Services Kiel GmbH, Kiel...   \n",
      "1  Novartis Investigative Site, Beijing, 100053, ...   \n",
      "2  Valley Endoscopy Center, Saint Clairsville, Oh...   \n",
      "3  Hospital San Donato, Milan, Milano, 20097, Ita...   \n",
      "4                                                NaN   \n",
      "\n",
      "                                     Study Documents  \n",
      "0  Study Protocol, https://cdn.clinicaltrials.gov...  \n",
      "1                                                NaN  \n",
      "2                                                NaN  \n",
      "3                                                NaN  \n",
      "4                                                NaN  \n",
      "         NCT Number                                        Study Title  \\\n",
      "count           500                                                500   \n",
      "unique          500                                                500   \n",
      "top     NCT03291782  D-0120 Safety and PK/PD, Food Effect Study in ...   \n",
      "freq              1                                                  1   \n",
      "mean            NaN                                                NaN   \n",
      "std             NaN                                                NaN   \n",
      "min             NaN                                                NaN   \n",
      "25%             NaN                                                NaN   \n",
      "50%             NaN                                                NaN   \n",
      "75%             NaN                                                NaN   \n",
      "max             NaN                                                NaN   \n",
      "\n",
      "                                           Study URL   Acronym Study Status  \\\n",
      "count                                            500       113          500   \n",
      "unique                                           500       113            9   \n",
      "top     https://clinicaltrials.gov/study/NCT03291782  INSTINCT    COMPLETED   \n",
      "freq                                               1         1          339   \n",
      "mean                                             NaN       NaN          NaN   \n",
      "std                                              NaN       NaN          NaN   \n",
      "min                                              NaN       NaN          NaN   \n",
      "25%                                              NaN       NaN          NaN   \n",
      "50%                                              NaN       NaN          NaN   \n",
      "75%                                              NaN       NaN          NaN   \n",
      "max                                              NaN       NaN          NaN   \n",
      "\n",
      "                                            Brief Summary Study Results  \\\n",
      "count                                                 500           500   \n",
      "unique                                                500             2   \n",
      "top     This initial clinical study in the US will be ...            NO   \n",
      "freq                                                    1           349   \n",
      "mean                                                  NaN           NaN   \n",
      "std                                                   NaN           NaN   \n",
      "min                                                   NaN           NaN   \n",
      "25%                                                   NaN           NaN   \n",
      "50%                                                   NaN           NaN   \n",
      "75%                                                   NaN           NaN   \n",
      "max                                                   NaN           NaN   \n",
      "\n",
      "       Conditions           Interventions        Primary Outcome Measures  \\\n",
      "count         500                     471                             490   \n",
      "unique        416                     469                             489   \n",
      "top       Healthy  OTHER: No intervention  Bioequivalence, within 30 days   \n",
      "freq           26                       2                               2   \n",
      "mean          NaN                     NaN                             NaN   \n",
      "std           NaN                     NaN                             NaN   \n",
      "min           NaN                     NaN                             NaN   \n",
      "25%           NaN                     NaN                             NaN   \n",
      "50%           NaN                     NaN                             NaN   \n",
      "75%           NaN                     NaN                             NaN   \n",
      "max           NaN                     NaN                             NaN   \n",
      "\n",
      "                               Secondary Outcome Measures  \\\n",
      "count                                                 403   \n",
      "unique                                                403   \n",
      "top     Pharmacokinetic: area under the plasma concent...   \n",
      "freq                                                    1   \n",
      "mean                                                  NaN   \n",
      "std                                                   NaN   \n",
      "min                                                   NaN   \n",
      "25%                                                   NaN   \n",
      "50%                                                   NaN   \n",
      "75%                                                   NaN   \n",
      "max                                                   NaN   \n",
      "\n",
      "                                   Other Outcome Measures      Sponsor  \\\n",
      "count                                                  38          500   \n",
      "unique                                                 38          340   \n",
      "top     Efficacy Endpoint, Reduction in embolic burden...  AstraZeneca   \n",
      "freq                                                    1           16   \n",
      "mean                                                  NaN          NaN   \n",
      "std                                                   NaN          NaN   \n",
      "min                                                   NaN          NaN   \n",
      "25%                                                   NaN          NaN   \n",
      "50%                                                   NaN          NaN   \n",
      "75%                                                   NaN          NaN   \n",
      "max                                                   NaN          NaN   \n",
      "\n",
      "       Collaborators  Sex                 Age  Phases     Enrollment  \\\n",
      "count             90  499                 500     342     493.000000   \n",
      "unique            89    3                   6       7            NaN   \n",
      "top           Sanofi  ALL  ADULT, OLDER_ADULT  PHASE1            NaN   \n",
      "freq               2  438                 344     109            NaN   \n",
      "mean             NaN  NaN                 NaN     NaN    3154.955375   \n",
      "std              NaN  NaN                 NaN     NaN   39031.384896   \n",
      "min              NaN  NaN                 NaN     NaN       0.000000   \n",
      "25%              NaN  NaN                 NaN     NaN      26.000000   \n",
      "50%              NaN  NaN                 NaN     NaN      87.000000   \n",
      "75%              NaN  NaN                 NaN     NaN     298.000000   \n",
      "max              NaN  NaN                 NaN     NaN  751725.000000   \n",
      "\n",
      "       Funder Type      Study Type                               Study Design  \\\n",
      "count          500             500                                        497   \n",
      "unique           1               3                                         87   \n",
      "top       INDUSTRY  INTERVENTIONAL  Observational Model: |Time Perspective: p   \n",
      "freq           500             422                                         75   \n",
      "mean           NaN             NaN                                        NaN   \n",
      "std            NaN             NaN                                        NaN   \n",
      "min            NaN             NaN                                        NaN   \n",
      "25%            NaN             NaN                                        NaN   \n",
      "50%            NaN             NaN                                        NaN   \n",
      "75%            NaN             NaN                                        NaN   \n",
      "max            NaN             NaN                                        NaN   \n",
      "\n",
      "       Other IDs Start Date Primary Completion Date Completion Date  \\\n",
      "count        500        494                     477             476   \n",
      "unique       500        393                     388             373   \n",
      "top     IBIO-201    2014-08                 2008-10         2015-12   \n",
      "freq           1          4                       5               5   \n",
      "mean         NaN        NaN                     NaN             NaN   \n",
      "std          NaN        NaN                     NaN             NaN   \n",
      "min          NaN        NaN                     NaN             NaN   \n",
      "25%          NaN        NaN                     NaN             NaN   \n",
      "50%          NaN        NaN                     NaN             NaN   \n",
      "75%          NaN        NaN                     NaN             NaN   \n",
      "max          NaN        NaN                     NaN             NaN   \n",
      "\n",
      "       First Posted Results First Posted Last Update Posted  \\\n",
      "count           500                  151                500   \n",
      "unique          469                  146                438   \n",
      "top      2008-04-01           2017-02-13         2024-09-19   \n",
      "freq              3                    2                  6   \n",
      "mean            NaN                  NaN                NaN   \n",
      "std             NaN                  NaN                NaN   \n",
      "min             NaN                  NaN                NaN   \n",
      "25%             NaN                  NaN                NaN   \n",
      "50%             NaN                  NaN                NaN   \n",
      "75%             NaN                  NaN                NaN   \n",
      "max             NaN                  NaN                NaN   \n",
      "\n",
      "                                                Locations  \\\n",
      "count                                                 431   \n",
      "unique                                                429   \n",
      "top     Kendle International Inc., Morgantown, West Vi...   \n",
      "freq                                                    2   \n",
      "mean                                                  NaN   \n",
      "std                                                   NaN   \n",
      "min                                                   NaN   \n",
      "25%                                                   NaN   \n",
      "50%                                                   NaN   \n",
      "75%                                                   NaN   \n",
      "max                                                   NaN   \n",
      "\n",
      "                                          Study Documents  \n",
      "count                                                  52  \n",
      "unique                                                 52  \n",
      "top     Study Protocol, https://cdn.clinicaltrials.gov...  \n",
      "freq                                                    1  \n",
      "mean                                                  NaN  \n",
      "std                                                   NaN  \n",
      "min                                                   NaN  \n",
      "25%                                                   NaN  \n",
      "50%                                                   NaN  \n",
      "75%                                                   NaN  \n",
      "max                                                   NaN  \n"
     ]
    }
   ],
   "source": [
    "print(df.info())\n",
    "print(df.describe(include='all')) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "af910e8d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "    NCT Number                                        Study Title  \\\n",
      "0  NCT03302091  A Study in People With Normal Kidney Function ...   \n",
      "1  NCT01948791  16w Interventional Study on Titration and Dose...   \n",
      "2  NCT04621591           Case Series With Saneso 360° Gastroscope   \n",
      "3  NCT03130491  European Study Evaluating the EMBLOK Embolic P...   \n",
      "4  NCT01580891  Evaluate the Clinical Equivalence of Two Nafti...   \n",
      "\n",
      "                                      Study URL   Acronym Study Status  \\\n",
      "0  https://clinicaltrials.gov/study/NCT03302091       NaN    COMPLETED   \n",
      "1  https://clinicaltrials.gov/study/NCT01948791  INSTINCT    COMPLETED   \n",
      "2  https://clinicaltrials.gov/study/NCT04621591       NaN    COMPLETED   \n",
      "3  https://clinicaltrials.gov/study/NCT03130491       NaN    COMPLETED   \n",
      "4  https://clinicaltrials.gov/study/NCT01580891       NaN    COMPLETED   \n",
      "\n",
      "                                       Brief Summary Study Results  \\\n",
      "0  The primary objective of the current study is ...           YES   \n",
      "1  To investigate the efficacy of Exelon capsule ...           YES   \n",
      "2  To confirm the procedural performance of the S...            NO   \n",
      "3  The primary objective is to evaluate the perfo...            NO   \n",
      "4  The objective of this study is to evaluate the...            NO   \n",
      "\n",
      "                    Conditions  \\\n",
      "0  Renal Insufficiency|Healthy   \n",
      "1          Alzheimer's Disease   \n",
      "2                EGD Procedure   \n",
      "3         Aortic Valve Disease   \n",
      "4                  Tinea Pedis   \n",
      "\n",
      "                                       Interventions  \\\n",
      "0                                   DRUG: BI 1467335   \n",
      "1                                       DRUG: ENA713   \n",
      "2                    DEVICE: Saneso 360° gastroscope   \n",
      "3  PROCEDURE: Transcatheter Aortic Valve Replacem...   \n",
      "4  DRUG: Naftifine HCl Cream 1%|DRUG: Naftin® (Na...   \n",
      "\n",
      "                            Primary Outcome Measures  \\\n",
      "0  Area Under the Concentration-time Curve of BI ...   \n",
      "1  Mean Change From Baseline in the Alzheimer's D...   \n",
      "2  Successful EGD, Procedure success is assessed ...   \n",
      "3  Performance Endpoint, successful insertion, pl...   \n",
      "4  Therapeutic Cure, Patients with both mycologic...   \n",
      "\n",
      "                          Secondary Outcome Measures  \\\n",
      "0  Area Under the Concentration-time Curve of BI ...   \n",
      "1  Change From Baseline in the Alzheimer's Diseas...   \n",
      "2  Endoscopist qualitative rating of the Saneso 3...   \n",
      "3  Safety Endpoint (Rate of MACCE), Rate of MACCE...   \n",
      "4                                                NaN   \n",
      "\n",
      "                              Other Outcome Measures  \\\n",
      "0                                                NaN   \n",
      "1                                                NaN   \n",
      "2                                                NaN   \n",
      "3  Efficacy Endpoint, Reduction in embolic burden...   \n",
      "4                                                NaN   \n",
      "\n",
      "                               Sponsor             Collaborators  Sex  \\\n",
      "0                 Boehringer Ingelheim                       NaN  ALL   \n",
      "1             Novartis Pharmaceuticals                       NaN  ALL   \n",
      "2                          Saneso Inc.  West Virginia University  ALL   \n",
      "3  Innovative Cardiovascular Solutions     Meditrial Europe Ltd.  ALL   \n",
      "4             Taro Pharmaceuticals USA                       NaN  ALL   \n",
      "\n",
      "                  Age  Phases  Enrollment Funder Type      Study Type  \\\n",
      "0  ADULT, OLDER_ADULT  PHASE1        20.0    INDUSTRY  INTERVENTIONAL   \n",
      "1  ADULT, OLDER_ADULT  PHASE4       222.0    INDUSTRY  INTERVENTIONAL   \n",
      "2  ADULT, OLDER_ADULT     NaN        22.0    INDUSTRY  INTERVENTIONAL   \n",
      "3  ADULT, OLDER_ADULT     NaN        28.0    INDUSTRY  INTERVENTIONAL   \n",
      "4  ADULT, OLDER_ADULT  PHASE1      1053.0    INDUSTRY  INTERVENTIONAL   \n",
      "\n",
      "                                        Study Design  \\\n",
      "0  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
      "1  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
      "2  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
      "3  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
      "4  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
      "\n",
      "                  Other IDs  Start Date Primary Completion Date  \\\n",
      "0  1386-0002|2017-002180-18  2017-10-17              2018-08-16   \n",
      "1              CENA713BCN05     2014-08                 2015-09   \n",
      "2               SAN360UGICL  2020-08-01              2020-08-30   \n",
      "3               CLP002-2016  2017-03-08              2021-11-01   \n",
      "4               NTFC 1105.0     2012-05                 2013-03   \n",
      "\n",
      "  Completion Date First Posted Results First Posted Last Update Posted  \\\n",
      "0      2018-08-16   2017-10-04           2021-06-04         2021-06-04   \n",
      "1         2015-09   2013-09-24           2017-02-13         2017-02-13   \n",
      "2      2020-09-09   2020-11-09                  NaN         2020-11-10   \n",
      "3      2022-01-28   2017-04-26                  NaN         2024-03-05   \n",
      "4         2013-07   2012-04-19                  NaN         2014-05-06   \n",
      "\n",
      "                                           Locations  \\\n",
      "0  CRS Clinical Research Services Kiel GmbH, Kiel...   \n",
      "1  Novartis Investigative Site, Beijing, 100053, ...   \n",
      "2  Valley Endoscopy Center, Saint Clairsville, Oh...   \n",
      "3  Hospital San Donato, Milan, Milano, 20097, Ita...   \n",
      "4                                                NaN   \n",
      "\n",
      "                                     Study Documents  \n",
      "0  Study Protocol, https://cdn.clinicaltrials.gov...  \n",
      "1                                                NaN  \n",
      "2                                                NaN  \n",
      "3                                                NaN  \n",
      "4                                                NaN  \n"
     ]
    }
   ],
   "source": [
    "print(df.head())\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2d3956e5",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6748d401",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "312011dc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Study Title</th>\n",
       "      <th>Study URL</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Study Status</th>\n",
       "      <th>Brief Summary</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Primary Outcome Measures</th>\n",
       "      <th>Secondary Outcome Measures</th>\n",
       "      <th>Other Outcome Measures</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Collaborators</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funder Type</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Design</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03302091</td>\n",
       "      <td>A Study in People With Normal Kidney Function ...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03302091</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The primary objective of the current study is ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Renal Insufficiency|Healthy</td>\n",
       "      <td>DRUG: BI 1467335</td>\n",
       "      <td>Area Under the Concentration-time Curve of BI ...</td>\n",
       "      <td>Area Under the Concentration-time Curve of BI ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>20.0</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NON_RANDOMIZED|Intervention Model:...</td>\n",
       "      <td>1386-0002|2017-002180-18</td>\n",
       "      <td>2017-10-17</td>\n",
       "      <td>2018-08-16</td>\n",
       "      <td>2018-08-16</td>\n",
       "      <td>2017-10-04</td>\n",
       "      <td>2021-06-04</td>\n",
       "      <td>2021-06-04</td>\n",
       "      <td>CRS Clinical Research Services Kiel GmbH, Kiel...</td>\n",
       "      <td>Study Protocol, https://cdn.clinicaltrials.gov...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT01948791</td>\n",
       "      <td>16w Interventional Study on Titration and Dose...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01948791</td>\n",
       "      <td>INSTINCT</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>To investigate the efficacy of Exelon capsule ...</td>\n",
       "      <td>YES</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>DRUG: ENA713</td>\n",
       "      <td>Mean Change From Baseline in the Alzheimer's D...</td>\n",
       "      <td>Change From Baseline in the Alzheimer's Diseas...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Novartis Pharmaceuticals</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE4</td>\n",
       "      <td>222.0</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>CENA713BCN05</td>\n",
       "      <td>2014-08</td>\n",
       "      <td>2015-09</td>\n",
       "      <td>2015-09</td>\n",
       "      <td>2013-09-24</td>\n",
       "      <td>2017-02-13</td>\n",
       "      <td>2017-02-13</td>\n",
       "      <td>Novartis Investigative Site, Beijing, 100053, ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT04621591</td>\n",
       "      <td>Case Series With Saneso 360° Gastroscope</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT04621591</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>To confirm the procedural performance of the S...</td>\n",
       "      <td>NO</td>\n",
       "      <td>EGD Procedure</td>\n",
       "      <td>DEVICE: Saneso 360° gastroscope</td>\n",
       "      <td>Successful EGD, Procedure success is assessed ...</td>\n",
       "      <td>Endoscopist qualitative rating of the Saneso 3...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Saneso Inc.</td>\n",
       "      <td>West Virginia University</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>22.0</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>SAN360UGICL</td>\n",
       "      <td>2020-08-01</td>\n",
       "      <td>2020-08-30</td>\n",
       "      <td>2020-09-09</td>\n",
       "      <td>2020-11-09</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020-11-10</td>\n",
       "      <td>Valley Endoscopy Center, Saint Clairsville, Oh...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03130491</td>\n",
       "      <td>European Study Evaluating the EMBLOK Embolic P...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT03130491</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The primary objective is to evaluate the perfo...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Aortic Valve Disease</td>\n",
       "      <td>PROCEDURE: Transcatheter Aortic Valve Replacem...</td>\n",
       "      <td>Performance Endpoint, successful insertion, pl...</td>\n",
       "      <td>Safety Endpoint (Rate of MACCE), Rate of MACCE...</td>\n",
       "      <td>Efficacy Endpoint, Reduction in embolic burden...</td>\n",
       "      <td>Innovative Cardiovascular Solutions</td>\n",
       "      <td>Meditrial Europe Ltd.</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>28.0</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: NA|Intervention Model: SINGLE_GROU...</td>\n",
       "      <td>CLP002-2016</td>\n",
       "      <td>2017-03-08</td>\n",
       "      <td>2021-11-01</td>\n",
       "      <td>2022-01-28</td>\n",
       "      <td>2017-04-26</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-03-05</td>\n",
       "      <td>Hospital San Donato, Milan, Milano, 20097, Ita...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT01580891</td>\n",
       "      <td>Evaluate the Clinical Equivalence of Two Nafti...</td>\n",
       "      <td>https://clinicaltrials.gov/study/NCT01580891</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>The objective of this study is to evaluate the...</td>\n",
       "      <td>NO</td>\n",
       "      <td>Tinea Pedis</td>\n",
       "      <td>DRUG: Naftifine HCl Cream 1%|DRUG: Naftin® (Na...</td>\n",
       "      <td>Therapeutic Cure, Patients with both mycologic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Taro Pharmaceuticals USA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>ADULT, OLDER_ADULT</td>\n",
       "      <td>PHASE1</td>\n",
       "      <td>1053.0</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>Allocation: RANDOMIZED|Intervention Model: PAR...</td>\n",
       "      <td>NTFC 1105.0</td>\n",
       "      <td>2012-05</td>\n",
       "      <td>2013-03</td>\n",
       "      <td>2013-07</td>\n",
       "      <td>2012-04-19</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2014-05-06</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                        Study Title  \\\n",
       "0  NCT03302091  A Study in People With Normal Kidney Function ...   \n",
       "1  NCT01948791  16w Interventional Study on Titration and Dose...   \n",
       "2  NCT04621591           Case Series With Saneso 360° Gastroscope   \n",
       "3  NCT03130491  European Study Evaluating the EMBLOK Embolic P...   \n",
       "4  NCT01580891  Evaluate the Clinical Equivalence of Two Nafti...   \n",
       "\n",
       "                                      Study URL   Acronym Study Status  \\\n",
       "0  https://clinicaltrials.gov/study/NCT03302091       NaN    COMPLETED   \n",
       "1  https://clinicaltrials.gov/study/NCT01948791  INSTINCT    COMPLETED   \n",
       "2  https://clinicaltrials.gov/study/NCT04621591       NaN    COMPLETED   \n",
       "3  https://clinicaltrials.gov/study/NCT03130491       NaN    COMPLETED   \n",
       "4  https://clinicaltrials.gov/study/NCT01580891       NaN    COMPLETED   \n",
       "\n",
       "                                       Brief Summary Study Results  \\\n",
       "0  The primary objective of the current study is ...           YES   \n",
       "1  To investigate the efficacy of Exelon capsule ...           YES   \n",
       "2  To confirm the procedural performance of the S...            NO   \n",
       "3  The primary objective is to evaluate the perfo...            NO   \n",
       "4  The objective of this study is to evaluate the...            NO   \n",
       "\n",
       "                    Conditions  \\\n",
       "0  Renal Insufficiency|Healthy   \n",
       "1          Alzheimer's Disease   \n",
       "2                EGD Procedure   \n",
       "3         Aortic Valve Disease   \n",
       "4                  Tinea Pedis   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0                                   DRUG: BI 1467335   \n",
       "1                                       DRUG: ENA713   \n",
       "2                    DEVICE: Saneso 360° gastroscope   \n",
       "3  PROCEDURE: Transcatheter Aortic Valve Replacem...   \n",
       "4  DRUG: Naftifine HCl Cream 1%|DRUG: Naftin® (Na...   \n",
       "\n",
       "                            Primary Outcome Measures  \\\n",
       "0  Area Under the Concentration-time Curve of BI ...   \n",
       "1  Mean Change From Baseline in the Alzheimer's D...   \n",
       "2  Successful EGD, Procedure success is assessed ...   \n",
       "3  Performance Endpoint, successful insertion, pl...   \n",
       "4  Therapeutic Cure, Patients with both mycologic...   \n",
       "\n",
       "                          Secondary Outcome Measures  \\\n",
       "0  Area Under the Concentration-time Curve of BI ...   \n",
       "1  Change From Baseline in the Alzheimer's Diseas...   \n",
       "2  Endoscopist qualitative rating of the Saneso 3...   \n",
       "3  Safety Endpoint (Rate of MACCE), Rate of MACCE...   \n",
       "4                                                NaN   \n",
       "\n",
       "                              Other Outcome Measures  \\\n",
       "0                                                NaN   \n",
       "1                                                NaN   \n",
       "2                                                NaN   \n",
       "3  Efficacy Endpoint, Reduction in embolic burden...   \n",
       "4                                                NaN   \n",
       "\n",
       "                               Sponsor             Collaborators  Sex  \\\n",
       "0                 Boehringer Ingelheim                       NaN  ALL   \n",
       "1             Novartis Pharmaceuticals                       NaN  ALL   \n",
       "2                          Saneso Inc.  West Virginia University  ALL   \n",
       "3  Innovative Cardiovascular Solutions     Meditrial Europe Ltd.  ALL   \n",
       "4             Taro Pharmaceuticals USA                       NaN  ALL   \n",
       "\n",
       "                  Age  Phases  Enrollment Funder Type      Study Type  \\\n",
       "0  ADULT, OLDER_ADULT  PHASE1        20.0    INDUSTRY  INTERVENTIONAL   \n",
       "1  ADULT, OLDER_ADULT  PHASE4       222.0    INDUSTRY  INTERVENTIONAL   \n",
       "2  ADULT, OLDER_ADULT     NaN        22.0    INDUSTRY  INTERVENTIONAL   \n",
       "3  ADULT, OLDER_ADULT     NaN        28.0    INDUSTRY  INTERVENTIONAL   \n",
       "4  ADULT, OLDER_ADULT  PHASE1      1053.0    INDUSTRY  INTERVENTIONAL   \n",
       "\n",
       "                                        Study Design  \\\n",
       "0  Allocation: NON_RANDOMIZED|Intervention Model:...   \n",
       "1  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "2  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "3  Allocation: NA|Intervention Model: SINGLE_GROU...   \n",
       "4  Allocation: RANDOMIZED|Intervention Model: PAR...   \n",
       "\n",
       "                  Other IDs  Start Date Primary Completion Date  \\\n",
       "0  1386-0002|2017-002180-18  2017-10-17              2018-08-16   \n",
       "1              CENA713BCN05     2014-08                 2015-09   \n",
       "2               SAN360UGICL  2020-08-01              2020-08-30   \n",
       "3               CLP002-2016  2017-03-08              2021-11-01   \n",
       "4               NTFC 1105.0     2012-05                 2013-03   \n",
       "\n",
       "  Completion Date First Posted Results First Posted Last Update Posted  \\\n",
       "0      2018-08-16   2017-10-04           2021-06-04         2021-06-04   \n",
       "1         2015-09   2013-09-24           2017-02-13         2017-02-13   \n",
       "2      2020-09-09   2020-11-09                  NaN         2020-11-10   \n",
       "3      2022-01-28   2017-04-26                  NaN         2024-03-05   \n",
       "4         2013-07   2012-04-19                  NaN         2014-05-06   \n",
       "\n",
       "                                           Locations  \\\n",
       "0  CRS Clinical Research Services Kiel GmbH, Kiel...   \n",
       "1  Novartis Investigative Site, Beijing, 100053, ...   \n",
       "2  Valley Endoscopy Center, Saint Clairsville, Oh...   \n",
       "3  Hospital San Donato, Milan, Milano, 20097, Ita...   \n",
       "4                                                NaN   \n",
       "\n",
       "                                     Study Documents  \n",
       "0  Study Protocol, https://cdn.clinicaltrials.gov...  \n",
       "1                                                NaN  \n",
       "2                                                NaN  \n",
       "3                                                NaN  \n",
       "4                                                NaN  "
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "01f1818c",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python (NEST)",
   "language": "python",
   "name": "nest"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
